Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer (STRONG-GEC)

NCT ID: NCT06497569Sponsor: H. Lee Moffitt Cancer Center and Research InstituteLast updated: 2026-04-01

Summary

The purpose of this study is to determine how the STRONG intervention compares with usual care for reducing malnutrition among gastroesophageal cancer patients.

Arms & interventions

  • BehavioralDietitian Consultation

    Participants will meet with a dietitian who will provide individualized nutrition counseling and dietary goals for calorie and protein intake. Bi-weekly, 30-minute dietitian telehealth visits will be conducted via ZOOM videoconferencing at the pre-intervention baseline visit, monthly during the intervention period (up to 90 days) and at the 4 and 6 month timepoints post-intervention.

  • BehavioralSurvey

    Surveys will be conducted using the PG-SGA short form19-21 and a brief symptom assessment tool that captures additional nutrition-impact symptoms not captured by the PG-SGA (e.g., swallowing difficulty) measured by the FACT Esophageal and Gastric Cancer scales and the FAACT anorexia/cachexia scales 22,23 through REDCap. Surveys are completed at the pre-intervention baseline visit and monthly during the intervention period prior to the dietitian visits (up to 90 days), and at the 4 and 6 month timepoints post-intervention.

  • BehavioralFitbit Data Collection

    Participants will log food intake while sharing their data with a dietitian during the 30-minute dietitian telehealth visits at the pre-intervention baseline visit, monthly during the intervention period (up to 90 days) and at the 4 and 6 month timepoints post-intervention.

  • BehavioralReferral to Dietitian

    Usual Care condition referral to a dietitian based on physician discretion.

  • BehavioralSocial Determinants of Health Survey (SDOH)

    Participants will complete a SDOH Survey that captures individual-level factors (insurance type, preferred language, educational attainment, annual household income, digital health literacy, financial toxicity, and self-reported barriers to care \[e.g., transportation\]) and structural-level factors (neighborhood disadvantage, rural residence). Digital health literacy will be measured using the validated eHEALS scale, an 8-item measure assessing confidence with finding, evaluating, and applying electronic information to inform health decision-making (score ≤ 30 indicates low literacy).

Outcome measures

Primary

  • Recruitment Rate- Feasibility

    The Study will be deemed feasible ≥ 50% of eligible patients are enrolled.

    Time frame: Up to 48 Months

  • Retention Rate- Feasibility

    The Study will be deemed feasible if ≥ 70% of participants enrolled at baseline are retained at the end of the intervention period.

    Time frame: Up to 90 Days

  • Patient-reported outcome completion-Feasibility

    The Study will be deemed feasible if ≥ 70% of participants enrolled submit 4 of the 6 study assessments.

    Time frame: Up to 6 Months

  • Food Log Data Collection-Feasibility

    The study will be deemed feasible if ≥ 70% of participants enrolled log food for greater than 80% of study days (72 out of 90).

    Time frame: Up to 6 Months

  • Adherence to Dietitian Visits- Feasibility

    The Study will be deemed feasible if ≥ 70% of participants enrolled attend 4 out of 6 dietitian visits.

    Time frame: Up to 6 Months

  • Fidelity to Study Protocol- Feasibility

    The Study will be deemed feasible if 20% of randomly audited dietitian visits have documented PG-SGA and calorie and protein goals

    Time frame: Up to 6 Months

  • Patient Rating of MyPlate app-Feasibility

    The Study will be deemed feasible if ≥ 70% of participants rate the MyPlate app as east-to use utilizing a validated usability scale (score ≥ 60).

    Time frame: Up to 6 Months

  • Participant Satisfaction- Acceptability

    Patient satisfaction with the intervention will be deemed acceptable if ≥ 70% of participants rate the intervention as satisfactory utilizing a validated 4 item scale (score range 0-20). A cutoff score of ≥ 12 based on prior studies to define intervention acceptability will be used.

    Time frame: Up to 6 Months

Secondary

  • Malnutrition -Nutritional Status

    Time frame: Baseline, 3 Months, 6 Months

  • Malnutrition-Significant weight loss

    Time frame: Baseline, 3 Months, 6 Months

  • Malnutrition - Low BMI

    Time frame: Baseline, 3 Months, 6 Months

  • Malnutrition - Low Skeletal Muscle Mass

    Time frame: Baseline, 3 Months, 6 Months

  • Quality of Life Questionnaires

    Time frame: Baseline, 3 Months, 6 Months

  • Treatment Adherence

    Time frame: Baseline, 3 Months, 6 Months

  • Progression Free Survival (PFS)

    Time frame: Up to 48 Months

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Participants must be 18 years of age or older * Participants must have locally advanced or metastatic gastroesophageal cancer (GEC) * Participants must plan to initiate chemotherapy and/or radiation therapy with a plan to have surgery or definitive treatment follow up at Moffitt * Participants must be able to speak and read Spanish and/or English * Participants must be able to provide informed consent Exclusion Criteria: * Participants have a documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g. severe dementia) * Use of feeding tubes at the time of study enrollment

Study locations (2)

Moffitt Cancer Center

Tampa, Florida, 33612

Recruiting
Amir Alishahi Tabriz, MD, phD, MPH · Principal Investigator
Jose Pimiento, MD · Principal Investigator

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27599

Recruiting
Kea Turner, PhD, MPH, MA · Contact
Kea Turner, PhD, MPH, MA · Principal Investigator

References

  • Turner K, Somasundaram A, Small BJ, Milano J, Santiago C, Sprow O, Hume E, Khajoueinejad N, McKinnie N, Pereira AL, Sinnamon A, Permuth JB, Tabriz AA, Pimiento JM. A patient-mediated implementation strategy to improve nutrition care delivery for esophageal and gastric cancer: a study protocol for a pilot randomized controlled trial. J Health Popul Nutr. 2025 Dec 28;45(1):37. doi: 10.1186/s41043-025-01208-3.(PubMed)